Effect of Simultaneous Treatment with Royal Jelly and Doxorubicin on the Survival of the Prostate Cancer Cell Line (PC3): An In Vitro Study
Journal Title: International Journal of Cancer Management - Year 2018, Vol 11, Issue 4
Abstract
Background: Doxorubicin (DOX) therapy is the first step in the treatment of several malignancies such as prostate cancer. Drug resistance is the main drawback of this agent. Royal jelly (RJ), used to prevent or cure many diseases, is a substance produced by honey bee. Objectives: The aim of this study was to determine the cytotoxic effect of DOX and RJ on prostate cancer cells, PC3. Methods: Cell viability of the three experimental groups (RJ-treated cells, DOX-treated cells and RJ followed by DOX-treated cells) was assessed by 3-(4,5-dimethylthiazoyl-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Results: RJ-treatment increased the cytotoxic effect of DOX on PC3 cells. Namely, the effect of low dose of DOX in combination with RJ was approximately similar to that of high dose of DOX without RJ combination. Conclusions: Any natural substances that amplify the cytotoxic effect of DOX and have the potential to save normal cells can be potentially used as a therapeutic agent which can decrease the side effects of DOX-treatment. RJ has shown to play this role in the present study.
Authors and Affiliations
Rouzbeh Mohammadi Abandansari, Hadi Parsian, Faranak Kazerouni, Roghaye Porbagher, Ebrahim Zabihi, Ali Rahimipour
Keywords
Related Articles
- EP ID EP365778
- DOI 10.5812/ijcm.13780
- Views 74
- Downloads 0
Comparison of Three Clinical Models for Estimating the Risk of Endometrial Cancer in Post-Menopausal Women with Abnormal Vaginal Bleeding
Background: Given the prevalence of abnormal post-menopausal bleeding and the importance of its early examination for ensuring the timely diagnosis of any malignancies, the present study was conducted to investigate uter...
The Effect of Polymorphisms on the Ala 119 Ser Gene Cytochrome P450 1B1*2 on the Susceptibility of Iranian Women to Develop Breast Cancer
Background Cytochrome P450 IBI (CYP1B1) is involved in the metabolism of a wide range of internal and external substrates and also plays a key role in the metabolism of oestrogen....
Association Between Cytochrome 1B1*3 Polymorphism and the Breast Cancer in a Group of IranianWomen
Background: As a hormone-dependent cancer, estrogen is involved in the development of breast cancer. CYP1B1 belongs to the P450 superfamily of enzymes and is involved in the metabolism of estrogen. The present study inve...
Clinicopathology Figures and Survival of Non-Hodgkin’s Lymphoma in Iran
Background: Non-Hodgkin’s lymphoma (NHL) is the fifth most frequently diagnosed cancer whose incidence has risen by at least 100 percent over the past five decades especially in theWest. Objectives: The aim of this study...
Bladder Cancer in Iran: Geographical Distribution and Risk Factors
Background To study overall and province-specific trends of bladder cancer incidence in Iran during 2004-2008 and to evaluate the association between bladder cancer incidence and...